Pharmacist’s attitudes and knowledge of pharmacogenomics and the factors that may predict future engagement
Author(s) -
Megan E. Hundertmark,
Stephen C. Waring,
David D. Stenehjem,
Danielle A. MacDonald,
David D. Sperl,
Ann Yapel,
Jacob T. Brown
Publication year - 2020
Publication title -
pharmacy practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.608
H-Index - 24
eISSN - 1886-3655
pISSN - 1885-642X
DOI - 10.18549/pharmpract.2020.3.2008
Subject(s) - pharmacogenomics , certification , pharmacy , pharmacist , medicine , family medicine , board certification , medical education , health care , survey instrument , nursing , psychology , residency training , pharmacology , continuing education , political science , law , economics , economic growth , applied psychology
Pharmacists who have completed a PGY-1 residency or received board certification appear more comfortable with interpretation and implementation of pharmacogenomic testing.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom